Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

DuPont Pioneer, Hexima Collaboration Targets Crop Protection

Published: Friday, February 14, 2014
Last Updated: Friday, February 14, 2014
Bookmark and Share
Companies partner to target transgenic protection of agricultural crops, such as soybean, cotton, corn, and rice to improve grower productivity.

Insect Protection Collaboration
The parties announced a new, multi-year insect protection gene discovery collaboration. The program combines the experience of Pioneer researchers in characterizing novel insect actives and trait development with Hexima's expertise in biochemistry and insect biology. The collaboration gives Pioneer exclusive rights for the commercial development of traits using genes discovered under the program. The global market for transgenic insect protection traits was estimated at US$6.5B in 2012.

Pioneer has taken a multi-pronged approach in its research program, leveraging both proprietary science and collaborations, to develop new modes of action against key insect pests. This agreement provides Pioneer with another source of insect protection leads for evaluation in its research program.

"We are developing multiple technologies to create new insect protection solutions for growers," said Gusui Wu, DuPont Pioneer senior research director. "Our collaboration with Hexima supports this strategy and allows us to pursue more options.  Hexima's excellent biochemical expertise combined with their access to Southern Hemisphere biodiversity represents a unique opportunity to discover new classes of insect actives." 

Multi-Gene Expression Vehicle (MGEV) License
As part of its alliance with Hexima, Pioneer also has secured a license to Hexima's Multi-Gene Expression Vehicle (MGEV) technology. The MGEV technology enables the delivery of several proteins to a plant from a single transformation event. Pioneer will have the ability to utilize the MGEV technology with leads coming from the Hexima collaboration, as well as under its own independent programs. Terms of the agreements were not disclosed.

Chairman Ross Dobinson commented that, "The instigation of a new, fully funded insect program reflects DuPont's confidence in the outstanding technical achievements of Hexima's scientists in our previous work. We look forward to continuing our already productive relationship with DuPont Pioneer."

The insect program will be Hexima's second largest research effort behind the disease resistance program, also in collaboration with Pioneer.



Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
World’s Largest Coral Gene Database
‘Genetic toolkit’ will help shed light on which species survive climate change.
A Boost for Regenerative Medicine
Growing tissues and organs in the lab for transplantation into patients could become easier after scientists discovered an effective way to produce three-dimensional networks of blood vessels, vital for tissue survival yet a current stumbling block in regenerative medicine.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Early Genetic Changes in Premalignant Colorectal Tissue Identified
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
Nanoparticles Target, Transform Fat Tissue
Nanoparticles designed to target white fat and convert it to calorie-burning brown fat slowed weight gain in obese mice without affecting food intake. This proof-of-concept work could lead to new therapies to treat obesity.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!